Please read these articles
http://boards.fool.co.uk/Message.asp?mid=7842473

http://www.advfn.com/cmn/fbb/thread.php3?id=3982666

http://www.medisys-group.com/Prelims_5_061202-1.pdf'

http://www.safetysyringesplus.com/info.htm

This has massive potential from products other than FUTURA which if it takes off will be the iceing on the cake.Let me give you the highlights from this Mays interims;

Financial Highlights

Financial performance improved significantly:

* Turnover increased by 9% to #20.1 million (2002: #18.4 million)

* Product sales increased by 25% on a constant US dollar exchange rate basis

* Earnings before interest, tax, depreciation and amortisation was #0.3
million (2002: EBITDA loss of #7.0 million, before exceptional items, as
restated)

* Gross margin 37% (2002: 33%)

* Selling, distribution and administration costs reduced to #4.8 million
(2002: #7.4 million before exceptional items)

* Profit before amortisation and research and development expenditure
#2.6 million (2002: loss of #0.8 million before exceptional items)

* Research and development expenditure #3.0 million (2002: #7.1 million,
as restated)

* Operating loss #1.3 million (2002: #9.2 million, before exceptional
items, as restated)

* Loss before tax #1.6 million (2002: #9.2 million, before exceptional
items, as restated)

* Loss per share 0.58p (2002: 2.58p, before exceptional items, as
restated)

Product Highlights

* Sales of existing products in line with expectations

- Sales of Assure range increased to #6.9 million (2002: #5.6 million)

- QuickTek sales to mail order market segment #2.6 million

- Sales of Futura Safety Scalpel #1.0 million in period

- Sales of Advance system #0.5 million in period

* Futura Safety Syringe and Flight disposable blood glucose monitoring
system remain on track for mid-2003 market launch

* Development of Spear capillary fill bio-sensor strip proceeding to
schedule.

Pretty impressive eh !!

Now since this we have had;

FDA approval for Hypogaurd

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=4778825&symbol=LSE%3AMDY

Futura passing final quality tests with Smiths

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=5023328&symbol=LSE%3AMDY

A partnership with Walmart for Flight

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=5194692&symbol=LSE%3AMDY

Launch of Spear

http://www.advfn.com/p.php?pid=nmona&cb=1064066532&article=5250424&symbol=LSE%3AMDY

Medisys "buy"

Monday, September 29, 2003 8:28:27 AM ET
Dryden Financial

LONDON, September 29 (New Ratings) Analyst I Broadhurst of Dryden Financial issues a "buy" rating on Medisys (MDY.L).

2003 New Ratings

Now this looks to me a company growing rapidly.The more I look into MDY the more confident I become of the potential rewards.These will not be instantaneous but will come over a period of time.Look at the turnaround in those figures posted above.Now that was in a recession.

http://www.charles-stanley.co.uk/content/SMI_oct03.pdf (see page 4)

http://www.research.reuters.co.uk/Research/Earnings.asp?ticker=MDY.L&country=GB&mxid=100068815&companyName=MEDISYS+PLC&sym=RE
VERY IMPORTANT MESSAGE TO ALL BUYERS/HOLDERS - PLEASE LISTEN

http://www.wallstreetreporter.com/profiles/Medisys.html

Comeon people let's look at this deal logically. For no debt on the books Medisys has struck a major deal with the No1 player in the US mail order diabetese market. To achieve the anticipated production they have done a placing which has been part underwritten by a major company which specialise in investing in growth companies http://www.altiumcapital.com/

This deal is anicipated to increase turnover dramatically whilst lowering overheads thus increasing profit margin....all good for the shareholder.

What happened prior was the retail investor sold out driving MDY to a very low share price whilst the likes of the MMs sat on 100Ks of stock and are now entitled to the placing as well.

The company would not IMO have struck this deal if there was any reservations from Liberty. Also Liberty must have shopped around and found the best partner. Now to go over some news that has already taken place but is in no way factored into the share price;

1. Succesful launch of the Futura syringe - we do not know what is currently happening although we do know that an order was placed by a major US distributor.

2. Walmart have confirmed that the Relion is now available and is available now. OK so Walmart had to place an initial stocking order. How many stores do they have ? Mmm could be interesting.

3. We have seen through research that the safety scalple is available through a number of distributors.

4. With Medisys's sales force going DIRECT the profit is not going to the middle man but direct to our company.

5. We have a major diabetese conference comming up where news could/should be released.

There are many other factors to suggest that people buy MDY stock but I think that one of the major issues is going to be the company moving into profitability very soon.

I wish all good luck long or short (burn ;-))

HOW COME ALL THE BUYING TODAY SOME NEWS BEING LEAKED ?

Looks like it may be turning.

Surely it is only rising today on the back of ZIM.

Up again today after the 1M buy. Also did you notice the P trade yesterday.

I can't see this rising in the v.short term - and where are the RNS on the site?

With new models of diabetic monitors and repeat business in the US the only problem is the USD-movement affecting profits. This is short-term and what we see is a company that has (at last) got to grips with reality and concentrated on its core business that is protected in some measure as it's repeated - once a diabetic, always a diabetic.
All at once we should see profits as their syringe R&D is disbanded. That's my hope and I took part in their fund-raising efforts to tide them over. It's a pity that some punters have taken fright because the Blue Sky has been switched off; but this co. is now Real.... Real products and real sales.

Something going on today.

One MM on the offer now.

Something going on today.

As a newcomer, what could be going on?

Rise was based on two facts as far as I can see;

1. Nomura had a large seller who was finally matched today thus eliminating the overhang.

2. Rumour of consolidation in the medical devices industry promting people to consider MDY as a possible takeover target
http://www.sharecast.com/cgi-bin/sharecast/story_list.cgi?title=Market%20Reports&id=0200,0201,0202,0203,0204,0210,0211,0220

When are the full year results going to be announced?.

Well is this the start of the recovery or another false dawn ? All the bad news is hopefully behind the company and the $ is recuperating which will transfer into greater turnover. Could be the time to get in prior to the new European distributor being announced.

Chart says it all ... fill yer boots.

Confirmation and BIG NEWS is about to be released.
Fill your boots indeed!

Facts please not speculation